We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27B
AUM Growth
+$1.49B
Cap. Flow
+$1.01B
Cap. Flow %
3.74%
Top 10 Hldgs %
56.43%
Holding
2,241
New
201
Increased
931
Reduced
698
Closed
165
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFBC icon
226
First Financial Bancorp
FFBC
$3.57B
$6.67M 0.02%
224,563
+4
+0% +$124
DE icon
227
Deere & Co
DE
$167B
$6.59M 0.02%
43,872
+1,147
+3% +$165K
RTN
228
DELISTED
Raytheon Company
RTN
$6.59M 0.02%
31,893
+1,504
+5% +$299K
TMO icon
229
Thermo Fisher Scientific
TMO
$209B
$6.5M 0.02%
26,615
+1,385
+5% +$319K
NCLH icon
230
Norwegian Cruise Line
NCLH
$9.03B
$6.42M 0.02%
111,699
SPGI icon
231
S&P Global
SPGI
$126B
$6.4M 0.02%
32,749
+1,645
+5% +$340K
IVE icon
232
iShares S&P 500 Value ETF
IVE
$48.9B
$6.38M 0.02%
55,113
+3,780
+7% +$434K
PID icon
233
Invesco International Dividend Achievers ETF
PID
$913M
$6.36M 0.02%
403,939
+3,260
+0.8% +$51.8K
NYF icon
234
iShares New York Muni Bond ETF
NYF
$1.36B
$6.22M 0.02%
114,400
MNDT
235
DELISTED
Mandiant, Inc. Common Stock
MNDT
$6.1M 0.02%
359,044
+10,653
+3% +$170K
LUV icon
236
Southwest Airlines
LUV
$22.3B
$6.08M 0.02%
97,417
+3,284
+3% +$192K
NVS icon
237
Novartis
NVS
$295B
$6.08M 0.02%
78,729
+14,148
+22% +$1.05M
GSK icon
238
GSK
GSK
$103B
$6.06M 0.02%
120,739
+42,518
+54% +$2.16M
KMB icon
239
Kimberly-Clark
KMB
$36.2B
$6.06M 0.02%
53,322
+7,520
+16% +$843K
EW icon
240
Edwards Lifesciences
EW
$48.5B
$6.03M 0.02%
103,974
-141
-0.1% -$6.9K
PAYX icon
241
Paychex
PAYX
$40.3B
$5.92M 0.02%
80,441
+41,528
+107% +$2.98M
YUMC icon
242
Yum China
YUMC
$14.8B
$5.92M 0.02%
168,686
+2,900
+2% +$103K
CL icon
243
Colgate-Palmolive
CL
$72.4B
$5.9M 0.02%
88,118
-7,395
-8% -$493K
PTLA
244
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.78M 0.02%
216,957
+82,055
+61% +$2.68M
TGT icon
245
Target
TGT
$62.3B
$5.74M 0.02%
65,023
+7,722
+13% +$642K
CWB icon
246
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.68B
$5.68M 0.02%
105,319
-9,274
-8% -$497K
BX icon
247
Blackstone
BX
$102B
$5.67M 0.02%
148,916
+27,246
+22% +$984K
SCHA icon
248
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$5.6M 0.02%
294,100
-31,652
-10% -$604K
AEP icon
249
American Electric Power
AEP
$73.7B
$5.57M 0.02%
78,639
+2,099
+3% +$149K
ED icon
250
Consolidated Edison
ED
$41.7B
$5.55M 0.02%
72,805
+1,499
+2% +$118K

Similar funds

Creative Planning's Q3 2018 Portfolio in Review

As of Q3 2018, Creative Planning held 2,241 positions worth $27B, up 5.9% from $25.5B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Creative Planning deployed $1.01B of net new capital in Q3 2018, opening 201 new positions and adding to 931 existing holdings. Its largest new stake was Helios and Matheson Analytics Inc.: 11,893,127 shares worth $180K.

By sector, the portfolio is most concentrated in Financials at 5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg Short Term High Yield Bond ETF, an estimated $85.9M trimmed.

  • Creative Planning's largest Q3 2018 buy was Helios and Matheson Analytics Inc.: 11,893,127 shares worth $180K.
  • Creative Planning added most to Vanguard Intermediate-Term Corporate Bond ETF in Q3 2018, an estimated $250M increase.
  • Creative Planning's biggest Q3 2018 reduction was State Street SPDR Bloomberg Short Term High Yield Bond ETF, cutting an estimated $85.9M.
  • Creative Planning fully exited Wgl Holdings in Q3 2018, selling an estimated $1.33M.
  • Creative Planning's ten largest holdings make up 56% of its $27B portfolio in Q3 2018.
  • Creative Planning opened 201 new positions and closed 165 in Q3 2018.
  • Creative Planning's portfolio value rose 5.9% quarter-over-quarter to $27B.

Based on Creative Planning's 13F filing for Q3 2018, filed 25 Oct 2018.